|
|
Volumn 54, Issue 5, 2011, Pages
|
|
Probiotic sepsis due to Saccharomyces fungaemia in a critically ill burn patient
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
ANTIBIOTIC AGENT;
BILIRUBIN;
CASPOFUNGIN;
FLUCONAZOLE;
FLUCYTOSINE;
ITRACONAZOLE;
KETOCONAZOLE;
PROBIOTIC AGENT;
RAVUCONAZOLE;
ULTRA LEVURE;
UNCLASSIFIED DRUG;
ADD ON THERAPY;
ADULT;
ANTIBIOTIC THERAPY;
ANTIFUNGAL SUSCEPTIBILITY;
BILIRUBIN BLOOD LEVEL;
BLOOD CULTURE;
BURN;
BURN EXCISION;
BURN PATIENT;
CANDIDA;
CASE REPORT;
CATHETER INFECTION;
CRITICALLY ILL PATIENT;
FEBRILE BONE MARROW APLASIA;
FEMALE;
FEVER;
FUNGEMIA;
FUNGUS ISOLATION;
HEPATOMEGALY;
HUMAN;
KLEBSIELLA PNEUMONIAE;
LETTER;
LIVER FAILURE;
MULTIPLE ORGAN FAILURE;
NUCLEOTIDE SEQUENCE;
PALLIATIVE THERAPY;
PRIORITY JOURNAL;
SACCHAROMYCES BOULARDII;
SACCHAROMYCES CEREVISIAE;
SEPTIC SHOCK;
SKIN TRANSPLANTATION;
ADULT;
BURNS;
CRITICAL ILLNESS;
DNA, FUNGAL;
FEMALE;
HUMANS;
MOLECULAR SEQUENCE DATA;
PHYLOGENY;
PROBIOTICS;
SACCHAROMYCES;
SEPSIS;
SEQUENCE ANALYSIS, DNA;
SACCHAROMYCES;
|
|
EID: 80052795222
PISSN: 09337407
EISSN: 14390507
Source Type: Journal
DOI: 10.1111/j.1439-0507.2010.01963.x Document Type: Letter |
|
Times cited : (19)
|
|
References (0)
|
